Intelligent Ultrasound Share Discussion Threads

[bamboo2] 20/12/2023 23:45

40F, assuming no takeover in the meantime.

I've seen a few, just as co turns profitable.

[40 fathoms] 20/12/2023 23:39

Once the market becomes confident that we will reach sustainable profitability, which should now only be @6months away, you will start to see a valuation that better reflect the companies prospects.

[bmcollins] 20/12/2023 12:56

@40 Fathoms
A great link, many thanks, I still fail to understand why this company has the lowly valuation that it does.
I guess so many aim investors, both institutional & private, have been burned so badly these past 2 years that they are prepared to look a gift horse in their mouth ?

[40 fathoms] 20/12/2023 09:21

Where Prof Alison Noble goes, IUG goes ! A video from a couple of weeks ago where she provides an introduction to the work she has been doing recently, much of which can be mapped to some of the patents that have been filed over the last 18 months.

I have teed the video up to where she starts to speak, she was given an 8 min introduction but for IUG holders she needs no introduction.

[bmcollins] 18/12/2023 21:31

@bamboo
Thanks for this information what a steal these IUG's seem to be at current prices
Your posts are much appreciated by me
Kind regards

[z1co] 06/12/2023 16:58

100,000 buy reported after close was why the offer price was increased to 9p.

[40 fathoms] 30/11/2023 01:25

The US military has just launched an evaluation and tender process for upto 6,000 battlefield POCUS ultrasound units. The results of which are to be announced in March or April next year. If we are to pick up contracts I expect our software will be integrated in to the winning system.

[bmcollins] 30/11/2023 01:13

Fathoms
Impressive input, I really appreciate it, thank you.
This Femoral Block as you say has just recently been approved & appears to make UIG a
likely supplier to the US Military in the near furure.
What I don't get is why the share price is still languishing, which to me is bizarre ?

[40 fathoms] 30/11/2023 00:47

This is one of the daily newsletters published from this weeks Interservice/Industry Training, Simulation and Education Conference (I/ITSEC)a US defence focused training and simulation based event. Page 10 - halfway down the middle column of attendees.

Without a doubt there is something brewing in the US military space. As further evidence I would point you to the following.



Please look at the interview on pages 12 to 15 .... but the key part is page 15. The last shaded block on the page.

Then I would point you to this



DAPRA have been putting money in to exploring this area .... I would also note that the requirements they were looking to fill was made public in spring 2021 and one of the areas of interest of DAPRA, in addition to ultrasound guided PNBs was around ultrasound guided intubation. I would then point you to the following patent we applied for in mid 2021 for tube placement.



I need to find the link again but my final item of evidence is that there are two specific requirements of the US Military to deploy an US Guided PNB product and they are 1) Must be FDA approved and must include a Femoral block.

We are the only FDA approved PNB product and when we initially got FDA approval we did not apply for the Femoral Block. I think it is interesting to note that we have subsequently applied for FDA approval of the Femoral Block and that was granted in October of this year.



Look at last column on page 3 to make it easy to understand.

[bamboo2] 27/11/2023 07:55

27 November 2023

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Update regarding Nominated Adviser and Broker

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that, following the completion of the all-share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), and as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

[40 fathoms] 25/11/2023 03:04

So I think it is obvious in LIC settings why our GA estimation software is so important .... however you could question what is the benefit in a HIC. Well I think if you look at this conclusion from a recent NIH paper you can deduce why. It is also worth noting that the study was funded by the Gates Foundation.

"Our best machine-learning based model estimates gestational age with a mean absolute error of 3.0 (95% CI, 2.9-3.2) and 4.3 (95% CI, 4.1-4.5) days in the second and third trimesters, respectively, which outperforms current ultrasound-based clinical biometry at these gestational ages. Our method for dating the pregnancy in the second and third trimesters is, therefore, more accurate than published methods."



More accurate than using clinical biometry ! This is huge, as with a few sweeps of the tummy you can get a more accurate estimate of GA than via finding, freezing and measuring various anatomical features. It will cut down the required sonographer workload for each scan by minutes and will allow improved resource planning around deliveries. This has significant economic potential.

[bmcollins] 24/11/2023 16:19

Gents, who would have thought that after the news this week we would be at 8.5p to 9p just before the close ?
Certainly not me, but I have kept nibbling, better luck next week hopefully.

[eeza] 23/11/2023 11:53

16 Jan I think for 4Q TU.

[bamboo2] 23/11/2023 11:25

eeza, I think early Jan'24 is the H2 2023 update, so there should be time, if they are interested! Obviously if there is something else brewing then no.

[eeza] 23/11/2023 10:48

Won't be able to, unless all inside info is public.

[bamboo2] 23/11/2023 10:33

It'd be good to see management buying at this level.
I think there is just time before the next closed period.

[bamboo2] 23/11/2023 07:29

23 November 2023

Intelligent Ultrasound announces launch of new gestational age estimation AI software, ScanNav FetalCheck and its use in first field study

PRESS RELEASE 23 November 2023: Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company specialising in artificial intelligence (AI) software and simulation, is pleased to announce a new AI development programme for gestational age estimation in prenatal care. ScanNav FetalCheck scanning technology aims to enable a non-skilled or skilled user to establish the gestational age (GA) accurately with minimal training.

Pregnant women are usually offered two routine ultrasound scans. The first at 11-14 weeks is performed to confirm viability of the fetus as well as the gestational age to pinpoint the likely due date. A second scan at 18-20 weeks focusses on detecting congenital abnormalities. Additional scans may be offered to monitor high-risk or complex pregnancies.

Having an accurate gestational age is important in the management of pregnancy, both to assess fetal growth and to inform treatment choice in the event that complications are seen. However, accurate determination of GA is difficult in low and middle -income countries (LMICs) as, currently, GA must be measured by trained sonographers, and very few front-line healthcare workers have the necessary skills.

Intelligent Ultrasound's ScanNav FetalCheck software aims to enable a non-skilled user to get an accurate GA with minimal training and without the need for an expensive high-end ultrasound machine. It has the potential to transform antenatal care both in LMICs and in high income countries (HICs) by allowing the age of the fetus to be assessed in a primary care setting where women need it.

Intelligent Ultrasound is also pleased to announce that a leading university in Africa has purchased four ScanNav FetalCheck systems as part of a trial to evaluate biomarkers and other factors which affect the probability of stillbirth.

ScanNav FetalCheck is currently not licenced for clinical use.

Aris Papageorghiou, Professor of fetal medicine at the University of Oxford said:

"Accurate estimation of gestational age is crucial for prenatal care: all aspects depend on knowledge of how far along the pregnancy journey a woman and her fetus are. In many low-income settings this is just not available, chiefly due to unavailability of expensive ultrasound equipment and trained staff. In this project, hand-held ultrasound and AI technology are being paired to overcome these roadblocks - this is disruptive technology that has the potential to allow better pregnancy care for all women."

Nicholas Sleep, COO at Intelligent Ultrasound said:

"The use of ScanNav FetalCheck in this first field study is a testament to the ease of use of our new AI software. Our mission is to make ultrasound easier to learn and simpler to use. This is the next step on our journey to achieving this and putting ultrasound into the hands of front-line health practitioners."

[eeza] 23/11/2023 07:05

RNS - gestational age estimation AI software launch

[bmcollins] 20/11/2023 17:06

@40 Fathoms
I have to agree with you, I added just a few more today but was surprised to see a weakish close, nevertheless I retain my optimism.

[40 fathoms] 20/11/2023 10:36

I think GEHC would make an offer anytime we indicated that we were ready, I don't think they would make a move without management approaching them first.

What that means in practice is we get sold when IP Group is ready to cash out. My own view is that IP Group or management would be mad to consider any T/O prior to 2026.

If all goes to plan we would have just made a profit of @ GBP 5 million for 2025, we will have a range of new products about to hit the market and a clear path to GBP 10 million in profit.

[eeza] 20/11/2023 10:14

Very much doubt they would buy a holding. They have very good comms with IUG management. Only obstacle would be whether they can make a T/O attractive enough to the management, to give up independence.

[bamboo2] 20/11/2023 09:28

40F, as we approach the anniversary of the last fundraise, do you think GEHC will look to aquire IUG?

If so, would we expect to see them start buying a holding first, or would they go straight to the directors?

Biggest holder is IPO Group/Parkwalk, who effectively control around 30%.

[40 fathoms] 20/11/2023 00:42

Bamboo - to your point the logic has to be that in time, Sonolyst will probably be incorporated as standard on all Volouson machines sold. If this is correct and it is included in next years Signature series launch then from Q4 next year onwards we will be receiving a royalty on @10,000+ unit sales per year (Expert + Signature and optional royalties on SWIFT).

Voluson has 3/4 products from high end to basic

Expert (Now included as standard) Sells @ 3,000 to 3,500 units per year
Signature (Should include SONOLYST next year) sells 6,000 to 7,000 units per year
Swift/Performance (SL included as optional extra on Swift) Sells @5,000 units per year.

As I mentioned before I also think the scope of Sonolyst will also be upgraded overtime and each capability increase will result in an incrementally higher royalty. They have already mentioned, 1st Trimester and 3rd Trimester Scans and it would be logical to think that Gestational Age will be included at some point.